General Announcement::Chairman & CEO Invests S$600,000 as Warrant Conversions Gain Momentum

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
09-Apr-2026 12:44:25
Status
New
Announcement Sub Title
Chairman & CEO Invests S$600,000 as Warrant Conversions Gain Momentum
Announcement Reference
SG260409OTHRYGYR
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Please see attached.

Attachments

Announcement - Warrant update 090426.pdf
Total size =156K